It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Dysfunction of motile cilia can impair mucociliary clearance in the airway and result in primary ciliary dyskinesia (PCD). We previously showed that mutations in central pair apparatus (CPA) genes perturb ciliary motility and result in PCD in mouse models. However, little is known about how epithelial cell types in the ciliary microenvironment of the upper airway respond to defects in ciliary motility and mucociliary clearance. Here, we have used single-cell RNA sequencing to investigate responses in tracheal epithelial cells from mice with mutations in CPA genes Cfap221/ Pcdp1, Cfap54, and Spef2. Expected cell types were identified, along with an unidentified cell type not expressing markers of typical airway cells. Deuterosomal cells were found to exist in two states that differ largely in expression of genes involved in differentiation into ciliated cells. Functional enrichment analysis of differentially expressed genes (DEGs) revealed important cellular functions and molecular pathways for each cell type that are altered in mutant mice. Overlapping DEGs shed light on general responses to cilia dysfunction, while unique DEGs indicate that some responses may be specific to the individual mutation and ciliary defect.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Pediatrics and Rare Diseases Group, Sanford Research, Sioux Falls, USA (GRID:grid.430154.7) (ISNI:0000 0004 5914 2142)
2 Sanford Research, Functional Genomics and Bioinformatics Core, Sioux Falls, USA (GRID:grid.430154.7) (ISNI:0000 0004 5914 2142)
3 Genetics and Genomics Group, Sanford Research, Sioux Falls, USA (GRID:grid.430154.7) (ISNI:0000 0004 5914 2142); Sanford School of Medicine of the University of South Dakota, Department of Pediatrics, Sioux Falls, USA (GRID:grid.267169.d) (ISNI:0000 0001 2293 1795)
4 Pediatrics and Rare Diseases Group, Sanford Research, Sioux Falls, USA (GRID:grid.430154.7) (ISNI:0000 0004 5914 2142); Sanford School of Medicine of the University of South Dakota, Department of Pediatrics, Sioux Falls, USA (GRID:grid.267169.d) (ISNI:0000 0001 2293 1795)